Lansdowne Partners and Bpifrance lead EUR30.6m Series A funding round in Depixus
Depixus, a biotechnology company developing technology for the fast, accurate, and straightforward extraction of multiomic information from DNA, RNA, and proteins, has raised EUR30.6 million in an oversubscribed Series A financing.